银杏达莫注射液治疗冠心病心绞痛(胸痹)的临床观察

目的观察银杏达莫注射液治疗冠心病心绞痛(胸痹)的疗效。方法以2007～2010就诊的92例冠心病患者为研究对象,所有患者均是C反应蛋白增高,对这些患者按照2003年世界卫生组织冠心病诊断标准进行诊断。将92例患者随机分为治疗组和对照组,对治疗组患者均静脉注射银杏达莫注射液20mL加入葡萄糖250mL,注射次数1次/d,对对照组患者均静脉注射鲁南欣康20mg加入葡萄糖250mL,注射次数1次/d。结果在症状改善的总有效率方面,治疗组89.1%与对照组76.1%有显著差异;心电图改善总有效率治疗组84.8%与对照组60.9%有显著差异;治疗组患者还明显改善了血液流变学,降低了血液黏度。结论银杏达莫注射液在治疗冠心病心绞痛(胸痹)方面有一定的疗效。

Objective Observation using ginkgo reach mo injection to the curative effect of treatment of coronary heart disease（angina） .methods 2004～2007 to our clinic of 92 cases with coronary artery disease for research object,All of the patients is c-reactive protein heighten,For these patients,the world health organization according to 2003 diagnostic criteria for diagnosis of coronary artery disease. 92 cases were randomly divided into the treatment group and control group,All patients to treatment group intraenous injection 20 mL of ginkgo biloba mughal joined glucose 250 mL,injection time 1 times/d,all patients in the control group of southern shandong hin intravenous 20mg join glucose 250 mL Cornwall,injection time 1 times/d,The results In the total efficiency improvement of symptoms,The treatment group 89.1% and controls the percentage of different significantly;Electrocardiogram（ecg） improve the total effective rate in treatment group and control group 47/67 84.8% of different significantly;The treatment group of patients also can significantly improve the blood rheology,reduced blood viscosity,Reduced blood viscosity.Conclusion Ginkgo reach mo injection in the treatment of coronary heart disease,（angina） aspects have certain curative effect.